Bio
Preeti Jain completed her Ph.D. in animal science from the Central Avian Research Institute, India, in 2009 and holds a master’s degree in biomedical sciences from Bundelkhand University, India. With 14 years of research experience on various infectious diseases at the National Institutes, Preeti has made significant contributions to numerous national health programs. Before joining ACSI India, Preeti was a research officer at the ICMR-National AIDS Research Institute, India.
創薬
Theranostics: How nuclear medicine is changing precision oncology
Nuclear medicine's theranostics approach enables "see it, treat it" cancer therapy using the same agents for diagnosis and treatment. Investment tripled to $14.86B in 2024 as these precision treatments move to early-stage care.
創薬
MAIT細胞はCAR-T免疫療法の未来となるのか？
MAIT細胞は他の非従来型T細胞と比べて比較的新しい発見であり、研究者たちはこれを「off-the-shelf（汎用型）」の免疫療法として応用する方向で研究を進めています。
.avif)
創薬
COVID-19以降のmRNAワクチンの未来
mRNAワクチンはCOVID-19以外の病気との戦いにどのように役立つことができるでしょうか？
安全性
New technologies to combat counterfeit drugs
Advanced packaging and on-drug labeling are new technologies to fight counterfeit drugs
バイオテクノロジー
Sensors drive better safety and performance
Science and wearable tech go hand in hand to provide athletes with precise, personalized information to improve their performance.
新興の科学分野
Latest developments in the global mpox outbreak
With recent headlines on monkeypox, learn more about the research landscape, scientific profiles, and currently available therapies. A deeper understanding of the published science enables clarity and insight on this emerging news story.
消費財
The latest sports technology innovations enhancing athletic performance
How do science and sportswear fit together? Explore the innovations in fabrics and materials that are creating sportswear that help athletes boost their performance.